- Home
- AMIX vs CNSP Comparison
AMIX vs CNSP Comparison
Compare AMIX & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMIX
- CNSP
- Stock Information
- Founded
- AMIX 2014
- CNSP 2017
- Country
- AMIX United States
- CNSP United States
- Employees
- AMIX N/A
- CNSP N/A
- Industry
- AMIX
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- AMIX
- CNSP Health Care
- Exchange
- AMIX NYSE
- CNSP Nasdaq
- Market Cap
- AMIX 7.3M
- CNSP 6.5M
- IPO Year
- AMIX N/A
- CNSP 2019
- Fundamental
- Price
- AMIX $3.21
- CNSP $0.10
- Analyst Decision
- AMIX
- CNSP Strong Buy
- Analyst Count
- AMIX 0
- CNSP 1
- Target Price
- AMIX N/A
- CNSP $0.50
- AVG Volume (30 Days)
- AMIX 971.1K
- CNSP 30.4M
- Earning Date
- AMIX 02-11-2025
- CNSP 11-15-2024
- Dividend Yield
- AMIX N/A
- CNSP N/A
- EPS Growth
- AMIX N/A
- CNSP N/A
- EPS
- AMIX N/A
- CNSP N/A
- Revenue
- AMIX N/A
- CNSP N/A
- Revenue This Year
- AMIX N/A
- CNSP N/A
- Revenue Next Year
- AMIX N/A
- CNSP N/A
- P/E Ratio
- AMIX N/A
- CNSP N/A
- Revenue Growth
- AMIX N/A
- CNSP N/A
- 52 Week Low
- AMIX $2.55
- CNSP $0.10
- 52 Week High
- AMIX $152.00
- CNSP $29.00
- Technical
- Relative Strength Index (RSI)
- AMIX 43.28
- CNSP 41.55
- Support Level
- AMIX $2.55
- CNSP $0.10
- Resistance Level
- AMIX $3.23
- CNSP $0.11
- Average True Range (ATR)
- AMIX 0.40
- CNSP 0.01
- MACD
- AMIX 0.19
- CNSP -0.00
- Stochastic Oscillator
- AMIX 41.51
- CNSP 7.69
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.